Allos Pharma

Science Pipeline Our Story News Publications

Loading…

We are a global team dedicated to improving the lives of patients with Fragile X Syndrome and Autism Spectrum Disorder. Our work spans three decades of research in neuroscience and neurodevelopmental disorders.

Explore

Science
Pipeline
Our Story
News
Publications
Contact
Privacy Policy

Stay informed

info@allospharma.com

Cambridge, Massachusetts

Arbaclofen is an investigational drug and has not been approved by the FDA or any regulatory authority.